Ifp Advisors, Inc Eli Lilly & CO Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ifp Advisors, Inc holds 11,323 shares of LLY stock, worth $8.53 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

11,323

Previous 10,717 5.65%

Holding current value

$8.53 Million

Previous $8.34 Million 22.96%

% of portfolio

0.42%

Previous 0.38%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $439,271 - $550,878	606 Added 5.65%	11,323 $10.3 Million
Q1 2024 Jul 30, 2024	SELL	$592.2 - $792.28 $466,061 - $623,524	-787 Reduced 6.84%	10,717 $8.34 Million
Q4 2023 Jan 09, 2024	BUY	$525.19 - $619.13 $215,853 - $254,462	411 Added 3.71%	11,504 $6.71 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $1.74 Million - $2.4 Million	4,010 Added 56.61%	11,093 $5.96 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $13,328 - $17,821	38 Added 0.54%	7,083 $3.32 Million
Q1 2023 Apr 18, 2023	SELL	$310.63 - $364.82 $2.38 Million - $2.79 Million	-7,654 Reduced 52.07%	7,045 $2.42 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $29,261 - $34,094	91 Added 0.62%	14,699 $843,000
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $389,278 - $443,623	1,313 Added 9.88%	14,608 $848,000
Q2 2022 Sep 06, 2022	BUY	$278.73 - $327.27 $3.71 Million - $4.35 Million	13,295 New	13,295 $770,000
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3.71 Million - $4.35 Million	-13,295 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$234.69 - $291.66 $2.25 Million - $2.79 Million	9,573 Added 257.2%	13,295 $3.81 Million
Q1 2022 Aug 08, 2022	BUY	$234.69 - $291.66 $233,985 - $290,785	997 Added 36.59%	3,722 $1.07 Million
Q4 2021 Jan 12, 2022	SELL	$224.85 - $279.04 $130,188 - $161,564	-579 Reduced 17.52%	2,725 $757,000
Q3 2021 Oct 06, 2021	SELL	$221.6 - $272.71 $44,984 - $55,360	-203 Reduced 5.79%	3,304 $765,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $62,289 - $80,571	-345 Reduced 8.96%	3,507 $803,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $33,685 - $43,607	-205 Reduced 5.05%	3,852 $722,000
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $49,313 - $65,254	-378 Reduced 8.52%	4,057 $684,000
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $13,890 - $16,067	95 Added 2.19%	4,435 $654,000
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $6,957 - $8,373	51 Added 1.19%	4,340 $708,000
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $23,214 - $28,733	195 Added 4.76%	4,289 $577,000
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $257,035 - $318,361	-2,404 Reduced 37.0%	4,094 $540,000
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $300,934 - $327,338	2,818 Added 76.58%	6,498 $730,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.34 Million - $1.58 Million	-12,030 Reduced 76.58%	3,680 $479,000
Q4 2018 Jan 23, 2019	SELL	$105.9 - $118.64 $334,855 - $375,139	-3,162 Reduced 16.75%	15,710 $1.82 Million
Q3 2018 Oct 25, 2018	BUY	$85.86 - $107.31 $90,839 - $113,533	1,058 Added 5.94%	18,872 $0
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $891,443 - $1.02 Million	-11,776 Reduced 39.8%	17,814 $0
Q1 2018 Jun 03, 2019	BUY	$74.21 - $87.6 $424,110 - $500,633	5,715 Added 23.94%	29,590 $2.5 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $424,110 - $500,633	-5,715 Reduced 19.31%	23,875 $0
Q4 2017 Jan 24, 2018	SELL	$81.94 - $87.89 $905,764 - $971,536	-11,054 Reduced 27.2%	29,590 $0
Q3 2017 Oct 30, 2017	SELL	$77.07 - $85.54 $83,158 - $92,297	-1,079 Reduced 2.59%	40,644 $3.48 Million
Q2 2017 Jun 03, 2019	BUY	N/A	6,623 Added 18.87%	41,723 $3.43 Million
Q1 2017 Jun 03, 2019	SELL	N/A	-1,347 Reduced 3.7%	35,100 $2.95 Million
Q4 2016 Jun 03, 2019	BUY	N/A	8,113 Added 28.63%	36,447 $2.68 Million
Q2 2016 Jun 03, 2019	BUY	N/A	24,654 Added 669.95%	28,334 $2.23 Million
Q1 2016 Jun 03, 2019	BUY	N/A	3,680	3,680 $479,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account